Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XG005 in acute pain following bunionectomy
NCT06017999Phase 3Completed
- Sponsor
- Xgene Pharmaceutical Inc.
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin naproxencarbil in acute pain, sponsored by Xgene Pharmaceutical Inc.. Started Aug 2023; status: completed.
02
Drugs
pregabalin naproxencarbil
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06017999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06017999.